Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Joensuu H, Fraser J, Wildiers H. et al
Effect of adjuvant trastuzumab for a duration of 9 weeks vs 1 year with concomitant chemotherapy for early human epidermal growth factor receptor 2-positive breast cancer: the SOLD randomized clinical trial.

JAMA Oncol 2018;
4 (09) 1199-1206

Bibliographische Angaben herunterladen

Aufrufen in: